Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine

Seminars in Arthritis and Rheumatism(2023)10.1016/j.semarthrit.2023.152177Source: DataRank Database

Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine is a research paper published in Seminars in Arthritis and Rheumatism (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.86)OA: greenTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Daniel H. Solomon ORCID,Yuezhou Chen ORCID,Jack Ellrodt ORCID,Mary Grace Whelan,Jacklyn Stratton

Live enrichment

PubMed:36796211 PMC:PMC9911151 OpenAlex:https://openalex.org/W4319661809

NIAMS NIH HHS

Grant: L30 AR070514

NIAMS NIH HHS

Grant: K08 AR072791

NIAMS NIH HHS

Grant: P30 AR072577

NIAMS NIH HHS

Grant: K23 AR075070

NIAMS NIH HHS

Grant: P30 AR070253

National Institutes of Health

Grant: 3K23AR075070-02S1

Studying pseudogout using natural language processing and novel imaging approaches

National Institutes of Health

Grant: 5P30AR070253-04

Joint Biology Consortium Resource-based Center

National Institutes of Health

Grant: 5K08AR072791-04

Molecular control of CD4 T cell ability to help B cells

Moderna Therapeutics Inc

NIH

Doris Duke Charitable Foundation

FWCI

1.86

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

greenLicense: Elsevier TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9911151/pdf/main.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0049017223000173?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0049017223000173?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9911151

Fields of Study

Rheumatoid Arthritis Research and TherapiesSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches03 medical and health sciences0302 clinical medicineHumansFemaleMiddle AgedMaleCOVID-19 VaccinesCOVID-19SARS-CoV-2Immunity, CellularAntirheumatic AgentsArthritis, RheumatoidRNA, MessengerImmunoglobulin G

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesArthritis, RheumatoidFemaleHumansImmunoglobulin GImmunity, CellularMaleMiddle AgedRNA, MessengerAntirheumatic Agents

Keywords

MedicineRheumatoid arthritisImmune systemImmunologyHumoral immunityAntibodyVaccinationCellular immunityInternal medicineVaccineimmunosuppressionDmardsCovid-19MaleImmunity, CellularCOVID-19 VaccinesSARS-CoV-2Middle AgedArticleArthritis, RheumatoidAntirheumatic AgentsImmunoglobulin GHumansFemaleRNA, Messenger

Sustainable Development Goals

SDG 0: Good health and well-being